Home › Chr. Hansen targets diabetes with next-generation probiotic deal
 

Keywords :   


Chr. Hansen targets diabetes with next-generation probiotic deal

2016-01-21 11:25:53| Chemicals - Topix.net

Many global pharma and food companies as well as new biotech companies are entering the domain focusing on clinical development of Microbiome-based products. Image credit: iStock.com A collaboration between Chr.

Tags: deal targets diabetes hansen

Category:Chemicals

Latest from this category

All news
11.05Weekly Recap: Hempel, Sherwin-Williams Top This Weeks Stories
10.05Three BASF Women in Manufacturing Honored at the 2024 Women MAKE Awards
10.05BASF Invests in Expansion of Additives Plant in Nanjing
10.05PPG Honored with American Chemistry Council Sustainability Leadership Award
10.05Indorama Ventures Achieves AA Rating from MSCI
09.05Maryland Adopts PaintCare Program
09.05Asian Paints Reports 4Q, Full FY 2024 Results
08.05Teknos\' Sustainability in 2023: Making the World Last Longer
Chemicals »
12.05California Bill Limits Skincare Sales to Teens & Persil Rebrands
12.05Kline Analysts Detail the Medical Dispensing Skin Care Market
12.05Glo30 Starts 2024 Strong with 60% Growth
12.05Zevo On-Body Repellent Teams with American Hiking Society To Provide Bug Bite Defense
12.05L\'Oréals Brand Value Soars to $13.4 Billion
12.05Spate Unveils the Top Sustainability Trends Cycling Google Searches
12.05Oh K! is the Most Searched Beauty Brand in the World: Cosmetify
12.05Zahawi confirms nearly 5m paid for tax error
More »